Variant Creutzfeldt-Jakob disease and plasma products: implementation of public health precautions in the UK

A Molesworth; H Janecek; N Gill; N Connor

doi:10.2807/esw.08.39.02552-en

Articles Open Access

Like 0

This item has no PDF Download

Variant Creutzfeldt-Jakob disease and plasma products: implementation of public health precautions in the UK
A Molesworth , H Janecek , N Gill , N Connor
View Citation Hide Citation

Citation style for this article: Molesworth A M, Janecek H, Gill N, Connor N. Variant Creutzfeldt-Jakob disease and plasma products: implementation of public health precautions in the UK. Euro Surveill. 2004;8(39):pii=2552. https://doi.org/10.2807/esw.08.39.02552-en

Previous Article
Table of Contents
Next Article

Abstract

The CJD Incidents Panel, a United Kingdom expert committee set up to advise on the management of ‘incidents’ of potential transmission of Creutzfeldt-Jakob disease) between patients, has issued recommendations